Ironwood Pharmaceuticals

US · IRWD #3609 by market cap

3.75 +0.12 +3.31%

Live - 5344 symbols - heartbeat 232s ago · 2026-10-08 08:58

Pre-market 3.80 +1.27%

After-hours 3.54 -5.59%

Overnight 3.72 -0.80%

Market cap: 619.65M
P/E (TTM): 4.75
P/B: -3.83
EPS: 0.15
Div yield: 0.00%
52W pos: 54%

Reader sentiment Are you bullish or bearish on IRWD?

Anonymous reader poll. Unscientific, not investment advice.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals, Inc. is a biotechnology company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Founded: 1998
CEO: Mr. Thomas A. McCourt
Employees: 100
Headquarters: Boston, Massachusetts, United States of America
Fiscal year end: 12-31
Website: ironwoodpharma.com

Company profile

Exchange: US
Symbol: IRWD
Market-cap rank: #3609
Market cap: 619.65M
Float cap: 512.84M
Shares out: 165.24M
Float shares: 136.76M

Sectors & themes

Drug Manufacturers - Specialty & Generic Global medical industry

Browse all sectors & themes

Quote time 2026-10-08 08:58:11 · For reference only, not investment advice and not tailored to your situation.